Delivery Order SPE2DB20D3103-SPE2DB23FN3J9
Award Date
5/9/23
Potential Completion Date
5/10/23
Potential Value
$5.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,287.99 firm fixed-price delivery order is for the supply of Cefepime-Dextrose 2 GM/50 MLS, a pharmaceutical product. The contract has an ultimate completion date of January 19, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,129.14 firm fixed-price delivery order is for the supply of 4565165651 CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product. The contract has an ultimate completion date of July 17, 2024. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,249.58 Firm Fixed Price Delivery Order is for the supply of 4561400728 - CEFEPIME-DEXTROSE 2 GM/50 MLS, with a completion date of July 5, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,813.60 firm fixed-price delivery order is for the supply of Cefepime-Dextrose 2 gram/50 mL, a critical antibiotic medication. The contract has an ultimate completion date of October 29, 2024 and was awarded on October 28, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,783.86 Firm Fixed Price Delivery Order is for the supply of CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,640.96 Firm Fixed Price Delivery Order covers the supply of the pharmaceutical product CEFEPIME-DEXTROSE 2 GM/50 MLS. This contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,211,439 units of the drug Cefepime-Dextrose 2 grams/50 mL. The firm-fixed-price delivery order has a ceiling value of $14,774.54 and a completion date of October 28, 2024. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,672.97, is a delivery order for the pharmaceutical product CEFEPIME-DEXTROSE 2 GM/50 MLS. It is not designated as a set-aside contract. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,328.77 firm fixed-price delivery order is for the procurement of CEFEPIME-DEXTROSE 1 GM/50 MLS, a medication used in the treatment of infections. The award has an ultimate completion date of September 26, 2023 and was not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,838.35, is for the supply of 4563433748 CEFEPIME-DEXTROSE 2 GM/50 MLS medical products. This is an open competition contract, with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...